These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16039125)

  • 1. Design, synthesis, and evaluation of novelly substituted benzimidazole compounds as angiotensin II receptor antagonists.
    Bali A; Bansal Y; Sugumaran M; Saggu JS; Balakumar P; Kaur G; Bansal G; Sharma A; Singh M
    Bioorg Med Chem Lett; 2005 Sep; 15(17):3962-5. PubMed ID: 16039125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological activities of novel nonpeptide angiotensin II receptor antagonists based on benzimidazole derivatives bearing a heterocyclic ring.
    Guo XZ; Shi L; Wang R; Liu XX; Li BG; Lu XX
    Bioorg Med Chem; 2008 Dec; 16(24):10301-10. PubMed ID: 18976926
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis and biological evaluation of 6-substituted aminocarbonyl benzimidazole derivatives as nonpeptidic angiotensin II AT1 receptor antagonists.
    Wang JL; Zhang J; Zhou ZM; Li ZH; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
    Eur J Med Chem; 2012 Mar; 49():183-90. PubMed ID: 22309912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and angiotensin II receptor antagonistic activities of benzimidazole derivatives bearing acidic heterocycles as novel tetrazole bioisosteres.
    Kohara Y; Kubo K; Imamiya E; Wada T; Inada Y; Naka T
    J Med Chem; 1996 Dec; 39(26):5228-35. PubMed ID: 8978851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and biological activity of 6-substituted carbamoyl benzimidazoles as new nonpeptidic angiotensin II AT₁ receptor antagonists.
    Zhang J; Wang JL; Zhou ZM; Li ZH; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
    Bioorg Med Chem; 2012 Jul; 20(14):4208-16. PubMed ID: 22727371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonpeptidic angiotensin II AT₁ receptor antagonists derived from 6-substituted aminocarbonyl and acylamino benzimidazoles.
    Zhang J; Wang JL; Yu WF; Zhou ZM; Tao WC; Wang YC; Xue WZ; Xu D; Hao LP; Han XF; Fei F; Liu T; Liang AH
    Eur J Med Chem; 2013 Nov; 69():44-54. PubMed ID: 24007859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, syntheses, and structure-activity relationships of novel NPY Y5 receptor antagonists: 2-{3-Oxospiro[isobenzofuran-1(3H),4'-piperidin]-1'-yl}benzimidazole derivatives.
    Ogino Y; Ohtake N; Nagae Y; Matsuda K; Moriya M; Suga T; Ishikawa M; Kanesaka M; Mitobe Y; Ito J; Kanno T; Ishihara A; Iwaasa H; Ohe T; Kanatani A; Fukami T
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5010-4. PubMed ID: 18723347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II--AT1 receptor antagonists: design, synthesis and evaluation of substituted carboxamido benzimidazole derivatives.
    Shah DI; Sharma M; Bansal Y; Bansal G; Singh M
    Eur J Med Chem; 2008 Sep; 43(9):1808-12. PubMed ID: 18158200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design and synthesis of orally efficacious benzimidazoles as melanin-concentrating hormone receptor 1 antagonists.
    Wu WL; Burnett DA; Caplen MA; Domalski MS; Bennett C; Greenlee WJ; Hawes BE; O'Neill K; Weig B; Weston D; Spar B; Kowalski T
    Bioorg Med Chem Lett; 2006 Jul; 16(14):3674-8. PubMed ID: 16690315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of 4'-[(benzimidazole-1-yl)methyl]biphenyl-2-sulfonamide derivatives as dual angiotensin II/endothelin A receptor antagonists.
    Bai R; Wei Z; Liu J; Xie W; Yao H; Wu X; Jiang J; Wang Q; Xu J
    Bioorg Med Chem; 2012 Aug; 20(15):4661-7. PubMed ID: 22750010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syntheses and structure-activity relationships of novel, potent, and selective trans-2-[3-oxospiro[isobenzofuran-1(3H),1'-cyclohexan]-4'-yl]benzimidazole NPY Y5 receptor antagonists.
    Ogino Y; Ohtake N; Nagae Y; Matsuda K; Ishikawa M; Moriya M; Kanesaka M; Mitobe Y; Ito J; Kanno T; Ishihara A; Iwaasa H; Ohe T; Kanatani A; Fukami T
    Bioorg Med Chem Lett; 2008 Sep; 18(18):4997-5001. PubMed ID: 18752943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-Substituted benzimidazoles as new nonpeptide angiotensin II receptor antagonists: synthesis, biological activity, and structure-activity relationships.
    Ries UJ; Mihm G; Narr B; Hasselbach KM; Wittneben H; Entzeroth M; van Meel JC; Wienen W; Hauel NH
    J Med Chem; 1993 Dec; 36(25):4040-51. PubMed ID: 8258826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Towards non-peptide ANG II AT1 receptor antagonists based on urocanic acid: rational design, synthesis and biological evaluation.
    Agelis G; Resvani A; Matsoukas MT; Tselios T; Kelaidonis K; Kalavrizioti D; Vlahakos D; Matsoukas J
    Amino Acids; 2011 Feb; 40(2):411-20. PubMed ID: 20607324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis, physicochemical properties and antimicrobial activity of some new benzimidazole derivatives.
    Ansari KF; Lal C
    Eur J Med Chem; 2009 Oct; 44(10):4028-33. PubMed ID: 19482384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relaxant activity of 2-(substituted phenyl)-1H-benzimidazoles on isolated rat aortic rings: design and synthesis of 5-nitro derivatives.
    Estrada-Soto S; Villalobos-Molina R; Aguirre-Crespo F; Vergara-Galicia J; Moreno-Díaz H; Torres-Piedra M; Navarrete-Vázquez G
    Life Sci; 2006 Jun; 79(5):430-5. PubMed ID: 16487544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of orally bioavailable benzimidazoles as Raf kinase inhibitors.
    Ramurthy S; Subramanian S; Aikawa M; Amiri P; Costales A; Dove J; Fong S; Jansen JM; Levine B; Ma S; McBride CM; Michaelian J; Pick T; Poon DJ; Girish S; Shafer CM; Stuart D; Sung L; Renhowe PA
    J Med Chem; 2008 Nov; 51(22):7049-52. PubMed ID: 18942827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of benzimidazole and imidazole compounds as potential aromatase inhibitors.
    Hida F; Robert J; Luu-Duc C
    Farmaco; 1994; 49(7-8):489-92. PubMed ID: 7945714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and in vitro cysticidal activity of new benzimidazole derivatives.
    Palomares-Alonso F; Jung-Cook H; Pérez-Villanueva J; Piliado JC; Rodríguez-Morales S; Palencia-Hernández G; López-Balbiaux N; Hernández-Campos A; Castillo R; Hernández-Luis F
    Eur J Med Chem; 2009 Apr; 44(4):1794-800. PubMed ID: 18582991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Penta-substituted benzimidazoles as potent antagonists of the calcium-sensing receptor (CaSR-antagonists).
    Gerspacher M; Altmann E; Beerli R; Buhl T; Endres R; Gamse R; Kameni-Tcheudji J; Kneissel M; Krawinkler KH; Missbach M; Schmidt A; Seuwen K; Weiler S; Widler L
    Bioorg Med Chem Lett; 2010 Sep; 20(17):5161-4. PubMed ID: 20685119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2-Aminobenzimidazoles as potent ITK antagonists: trans-stilbene-like moieties targeting the kinase specificity pocket.
    Lo HY; Bentzien J; Fleck RW; Pullen SS; Khine HH; Woska JR; Kugler SZ; Kashem MA; Takahashi H
    Bioorg Med Chem Lett; 2008 Dec; 18(23):6218-21. PubMed ID: 18930400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.